Equity Method Investment (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
|
Jan. 15, 2026
shares
|
Jun. 30, 2026
USD ($)
seat
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
seat
|
Jun. 30, 2025
USD ($)
|
|
| Schedule of Equity Method Investments [Line Items] | |||||
| Gain on VIE's sale of IPR&D assets | $ 0 | $ 0 | $ 19,000 | $ 0 | |
| Bisirna Therapeutics, Inc. | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Gain on VIE's sale of IPR&D assets | $ 19,000 | ||||
| Voting interest | 25.29% | 25.29% | |||
| Number of seats on board of directors | seat | 1 | 1 | |||
| Equity method investments | $ 2,200 | $ 2,200 | |||
| Bisirna Therapeutics, Inc. | Series A Preferred Stock | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Shares in exchange of IPR&D assets transferred (in shares) | shares | 6,625,000 | ||||
| Bisirna Therapeutics, Inc. | Common Stock | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Shares in exchange of IPR&D assets transferred (in shares) | shares | 26,500,000 | ||||
| X | ||||||||||
- Definition Equity Method Investment, Shares Received No definition available.
|
| X | ||||||||||
- Definition Number Of Seats On Board Of Directors No definition available.
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|